NT5E and melanoma: Expression of AR and the ectonucleosidases in cancers has been described for both CD73 (e.g., CRC, prostate, breast, HNSCC, ovarian, and melanoma) and CD39 (e.g., melanoma, ovarian, head, and neck cancer) [127].